About
5th Gamma Delta T Therapies Summit - What's It About?
Gamma Delta T Therapies continue to spark interest whereby their unique biological features are being targeted to better tackle solid tumors. In 2024, the community is poised at a pivotal juncture, intensifying efforts to comprehensively grasp the clinical safety and efficacy of gamma delta T therapies. This summit aims to solidify confidence in the transformative potential of this approach within the realms of cell therapy and antibody development.
Bootcamp
Day
Explores past and present clinical insights to forecast future therapeutic directions, the potential of epigenetic reprogramming to maximize therapeutic efficacy, implementing best practices in manufacturing gamma delta T cells for quality, scalability, and safety in clinical applications
Research & Translational Development
Explore how to fine tune mechanisms of gamma delta T cells for precise solid tumor targeting and treating autoimmune diseases
Clinical Development & Product Optimization
Discover the best practises when organising clinical trial design and appeasing regulators to fast track pipelines into the clinic and beyond
Scientific Poster Session
This is your opportunity to share your work and gain exposure for your research, and foster discussion with many of the brightest minds.
“There was an excellent mix of academia and drug developer folks, so this is a great venue of learning gdT cell biology and the progress of developing gdT cell therapies”
– Associate Principal Scientist, Merck & Co - Past Delegate